Adverum Biotechnologies, Inc. (ADVM)

NASDAQ: ADVM · Real-Time Price · USD

2.215

-0.495 (-18.27%)

At close: May 13, 2025, 4:00 PM

2.250

+0.035 (1.58%)

After-hours: May 13, 2025, 5:50 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2021	FY 2019	FY 2018	FY 2017	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2016 - 2018
Gene Therapeutics	3.60M	Log In	Log In	Log In	Log In	Upgrade
Gene Therapeutics Growth	-52.00%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2021	FY 2019	FY 2018	FY 2017	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2016 - 2018
United States	3.60M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-52.00%	Log In	Log In	Log In	Log In	Upgrade